MIF and prostate carcinoma: A reduction of tumor growth was also observed in sub-cutaneous human neuroblastoma [20] and prostate cancer xenografts [21], after inhibition of MIF expression by MIF antisens transfection or RNA interference or after treatment with anti-MIF antibodies or MIF inhibitors.